Federal contract award
75N93019C00054
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $35.6M |
| Current contract value | $35.6M |
| Potential contract value / ceiling | $184.4M |
| Start date | Sep 16, 2019 |
| Current end date | Dec 31, 2030 |
| Potential end date | Dec 31, 2030 |
| Latest award activity | Jul 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 26 of 26 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 23, 2026 | P00025 | $-141.2K | EO 14398 - COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Dec 19, 2025 | P00024 | $7.0M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026) |
| Sep 25, 2025 | P00023 | $257.8K | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026) |
| Aug 6, 2025 | P00022 | $861.3K | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Jul 14, 2025 | P00021 | $806.1K | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Mar 6, 2025 | P00020 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Sep 25, 2024 | P00019 | $-375.7K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Aug 15, 2024 | P00018 | $1.7M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Jul 31, 2024 | P00017 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Apr 19, 2024 | P00016 | $-109.8K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Jan 29, 2024 | P00015 | $781.3K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Dec 18, 2023 | P00014 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Aug 21, 2023 | P00013 | $772.5K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Aug 10, 2023 | P00012 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| May 10, 2023 | P00011 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Mar 13, 2023 | P00010 | $2.7M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Jul 25, 2022 | P00009 | $752.0K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| Apr 1, 2022 | P00008 | $1.4M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Feb 7, 2022 | P00007 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Nov 14, 2021 | P00006 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Jun 22, 2021 | P00005 | $738.4K | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Apr 30, 2021 | P00004 | $1.3M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Feb 22, 2021 | P00003 | $2.4M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Aug 12, 2020 | P00002 | $3.8M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Jun 25, 2020 | P00001 | $3.1M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
| Sep 16, 2019 | 0 | $7.9M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) |
Estimated positioning window
Dec 31, 2029 – Jun 30, 2030
Recompete signal: . Rule-based research score; positioning dates are estimates.
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2030-12-31 (1521 days from calculation)
- +5 points
- 155 historical awards in this buyer and category group
- +15 points
- 26 recorded award transactions
- +10 points
- Latest award action: 2026-07-23
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.